2023 -
now Immunogenicity Scientific Advisor @ Immunogenicity and Immunotoxicity Consulting
2023 -
2025 Associate Director @
2021 -
2023 Principal Scientist @
2019 -
2021 Scientist @
2016 -
2019 Scientist II @
2015 -
2016 Scientist Biochemical Assays @
2010 -
2015 Scientist II @
2007 -
2010 Biochemist II @ Siemens AG
2001 -
2007 Biochemist @
Stephen Bradley Education
Northeastern University
M.S. (Biotechnology, Pharmaceutical Science)
2005
-
2009
Northeastern University
B.S (Biology)
1997
-
2002
Stephen Bradley Skills
Liaison
Translational Medicine
Good Clinical Practice (GCP)
Bioanalysis
Regulatory Submissions
EMA
Cytokines
Cell Phenotyping
Anti-Drug Antibodies
Management
Project Leadership
Outsourcing Management
Clinical Trials
Bioanalytical
DMPK
Complement
Immunogenicity Risk Assessment
Liquid Chromatography-Mass Spectrometry (LC-MS)
Ligand Binding Assays
Immunogenicity
Document Preparation
Clinical Pharmacology
Assay Development
ELISA
Drug Discovery
Biomarkers
Biotechnology
Biochemistry
Immunoassays
Drug Development
Validation
Antibodies
Oncology
Laboratory Automation
GMP
Immunology
GLP
Pharmacokinetics
Cardiovascular Disease
Diagnostics
Pharmacodynamics
Antibody Development
Hybridoma Technology
Cardiovascular Research
Molecular Biology
Cell Culture
In Vitro
FDA
HPLC
Chromatography
SEC
Patent Applications
Experion
Surface Plasmon
Surgery
In Vivo
ISO
Multiple Therapeutic Areas
Target Identification
Surface Plasmon Resonance
Clinical Research
LCMS
Htrf
Interferometry
Hsp
SPR
Ecl
Road
SEP IRA
Batch Processing
Mass Spectrometry
Biacore
Disease
Cancer
HTTPS
Robotics
Immunoprecipitation
Jamaica
Science
Localization
Spotfire
Personalized Medicine
Guiding
Beckman
Mouse
IVD
Protein Chemistry
PK/PD
Gel
Boston
Publications
Blood
Siemens
Human Resources
Cardiovascular
Fusion
Networking
Dispensers
Cell
PCR
Ovarian
Analytical Biochemistry
Healthcare
Strategy
Subcloning
Internet Protocols
Microsoft Office
Medicine
Testing
Jco
Commercial Launch
Phage Display
Modulation
Sds
Plasma Physics
Institutes
Akta
Barrier
Rt Pcr
Scheduling
Project Management
American
Research
Softmax Pro
System Monitoring
Commercial Real Estate
Hardware
Molecular
Medical Research
Laboratory
Thermo
Cell Lines
Ligand Binding
Washers
Western Blotting
Immunization
Buffer
Accountability
Applications
Communication
Brain
Life Sciences
DNA
GraphPad Prism
Southern Blot
Novartis
Characterization
Purification
Stage
Filtration
Luminex
High Throughput
Array
Measurements
Hybridoma
Evo
Nsclc
Ief
LinkedIn
ISO 13485
Ret
Internal Audit
Therapists
Labelling
High Throughput Screening
International
Type 2 Diabetes
CRO
Biology
Conceived
Bioreactor
Gel Electrophoresis
Software Installation
Sample Prep
Expression
Chemiluminescence
Guidelines
FPLC
Medical Devices
Software
Hybridization
Multiplexing
Plain
FX Options
Proposal Writing
Pharmaceutics
Separation
Manufacturing
Pancreatic
Size Exclusion
Computer Diagnostics
Biologics
Serum
Lc Ms
Infinity
Colon
Plate
Pharmaceutical Industry
Filing
DNA extraction
Abstraction
Chip
Tissue Culture
Prototype
Stephen Bradley Summary
Stephen Bradley, based in United States, is currently a Senior Director at Solid Biosciences. Stephen Bradley brings experience from previous roles at Immunogenicity and Immunotoxicity Consulting, Alexion Pharmaceuticals, Inc., Apellis Pharmaceuticals and Mersana Therapeutics. Stephen Bradley holds a 2005 - 2009 M.S. in Biotechnology, Pharmaceutical Science @ Northeastern University. With a robust skill set that includes Liaison, Translational Medicine, Good Clinical Practice (GCP), Bioanalysis, Regulatory Submissions and more. Stephen Bradley has 2 emails and 3 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.